MSc Artificial Intelligence for Drug Discovery

The Artificial Intelligence for Drug Discovery MSc is a comprehensive program offered by Queen Mary University of London. This interdisciplinary course aims to equip students with the foundational knowledge and practical skills to apply AI techniques to drug discovery and design. Working at the interface of computer science, molecular biology and chemistry, and clinical science and medicine, students will gain fundamental insights into how drugs interact with their biological targets.Course Content: The program curriculum includes modules that cover both the theoretical and applied aspects of AI in drug discovery. These study areas include machine learning, structural bioinformatics, biomedical ethics, and data analysis and visualisation. Students are encouraged to tackle complex problems experimentally and theoretically, and to design, implement, and evaluate solutions for real-world drug development. Key Modules: This course is divided into several key modules such as Artificial Intelligence in Medicine, Structural Bioinformatics and Computational Drug Design, Applied Data Analysis and Visualisation, Machine Intelligence for Healthcare, and Research in Biomedical Engineering Group Project.Future Careers: Graduates of this program can expect to find employment opportunities in a variety of sectors and roles such as in academia, research institutes, hospitals, pharmaceutical and biomedical companies, consulting firms, or government agencies. They may find roles as data scientists, computational biologists, bioinformaticians, AI specialists, or software developers for biological or medical applications.For more information on this course, please visit the official course page.